Compare Burlington Stores Inc (BURL) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Burlington Stores Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Burlington Stores Inc trades at $359.42 (market cap $22.59B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.6× Burlington Stores Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Burlington Stores Inc pays none. Which is the better fit depends on your goals.
| BURL | REGN | |
|---|---|---|
Market Cap | $22.59B | $82.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $372.19 | $812.27 |
52-Week Low | $242.43 | $555.51 |
Enterprise Value | $27.71B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Burlington Stores Inc
Burlington is a leading off-price retailer in the US, offering branded apparel, footwear, and home goods at significant discounts. It operates hundreds of stores focused on delivering high-quality products at great value.
Read more on BURL →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
